Your browser doesn't support javascript.
loading
Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting.
Pawaskar, M; Li, Q; Hoogwerf, B J; Reynolds, M W; Faries, D; Engelman, W; Bruhn, D; Bergenstal, R M.
Affiliation
  • Pawaskar M; Eli Lilly and Company, Indianapolis, IN, USA.
Diabetes Obes Metab ; 14(7): 626-33, 2012 Jul.
Article in En | MEDLINE | ID: mdl-22321776
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Venoms / Blood Glucose / Weight Loss / Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Ambulatory Care / Hypoglycemic Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Venoms / Blood Glucose / Weight Loss / Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Ambulatory Care / Hypoglycemic Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom